Claudia Rl Cardoso1, Raphael Am Moraes1, Nathalie C Leite1, Gil F Salles2. 1. Department of Internal Medicine, University Hospital Clementino Fraga Filho, Medical School, Universidade Federal do Rio de Janeiro, Rua Rodolpho Rocco 255, Rio de Janeiro 21941-913, Brasil. 2. Department of Internal Medicine, University Hospital Clementino Fraga Filho, Medical School, Universidade Federal do Rio de Janeiro, Rua Rodolpho Rocco 255, Rio de Janeiro 21941-913, Brasil. Electronic address: gilsalles@hucff.ufrj.br.
Abstract
AIMS: Reduced heart rate variability (HRV), an early sign of diabetic cardiovascular autonomic neuropathy (CAN), is associated with worse cardiovascular outcomes. The objective was to evaluate relationships between HRV parameters and three pre-clinical cardiovascular disease markers (left ventricular hypertrophy [LVH], aortic stiffness and carotid atherosclerosis) in type 2 diabetes. METHODS: In a cross-sectional study, 313 patients with type 2 diabetes performed 24-h Holter monitoring, carotid ultrasonography (intima-media thickness and plaques measurements), aortic pulse wave velocity measurement and echocardiography (left ventricular mass index [LVMI] measurement). Time-domain HRV parameters were the standard deviation of all normal RR intervals (SDNN), the standard deviation of the averaged normal RR intervals for all 5min segments (SDANN), the root mean square of differences between adjacent R-R intervals (rMSSD), and the percentage of adjacent R-R intervals that varied by >50ms (pNN50). Multivariate linear and logistic regressions assessed associations between HRV parameters and the three markers of pre-clinical cardiovascular disease. RESULTS: Patients with reduced HRV had longer diabetes duration, greater prevalences of microvascular complications, lower physical fitness, and higher heart rate, glycated hemoglobin, albuminuria and LVMI than patients with normal HRV. On multivariate regressions, after adjustments for several confounders, reduced SDNN and SDANN were independently associated with LVH and aortic stiffness. No HRV parameter was associated with carotid atherosclerosis. CONCLUSIONS: Two reduced HRV parameters, SDNN and SDANN, which reflect cardiovascular autonomic imbalance, were associated with LVH and aortic stiffness, markers of pre-clinical cardiovascular disease. These findings may offer insights into physiopathological mechanisms linking CAN to worse cardiovascular prognosis.
AIMS: Reduced heart rate variability (HRV), an early sign of diabetic cardiovascular autonomic neuropathy (CAN), is associated with worse cardiovascular outcomes. The objective was to evaluate relationships between HRV parameters and three pre-clinical cardiovascular disease markers (left ventricular hypertrophy [LVH], aortic stiffness and carotid atherosclerosis) in type 2 diabetes. METHODS: In a cross-sectional study, 313 patients with type 2 diabetes performed 24-h Holter monitoring, carotid ultrasonography (intima-media thickness and plaques measurements), aortic pulse wave velocity measurement and echocardiography (left ventricular mass index [LVMI] measurement). Time-domain HRV parameters were the standard deviation of all normal RR intervals (SDNN), the standard deviation of the averaged normal RR intervals for all 5min segments (SDANN), the root mean square of differences between adjacent R-R intervals (rMSSD), and the percentage of adjacent R-R intervals that varied by >50ms (pNN50). Multivariate linear and logistic regressions assessed associations between HRV parameters and the three markers of pre-clinical cardiovascular disease. RESULTS:Patients with reduced HRV had longer diabetes duration, greater prevalences of microvascular complications, lower physical fitness, and higher heart rate, glycated hemoglobin, albuminuria and LVMI than patients with normal HRV. On multivariate regressions, after adjustments for several confounders, reduced SDNN and SDANN were independently associated with LVH and aortic stiffness. No HRV parameter was associated with carotid atherosclerosis. CONCLUSIONS: Two reduced HRV parameters, SDNN and SDANN, which reflect cardiovascular autonomic imbalance, were associated with LVH and aortic stiffness, markers of pre-clinical cardiovascular disease. These findings may offer insights into physiopathological mechanisms linking CAN to worse cardiovascular prognosis.
Authors: Cristian Pattaro; Martin Gögele; Deborah Mascalzoni; Roberto Melotti; Christine Schwienbacher; Alessandro De Grandi; Luisa Foco; Yuri D'Elia; Barbara Linder; Christian Fuchsberger; Cosetta Minelli; Clemens Egger; Lisa S Kofink; Stefano Zanigni; Torsten Schäfer; Maurizio F Facheris; Sigurður V Smárason; Alessandra Rossini; Andrew A Hicks; Helmuth Weiss; Peter P Pramstaller Journal: J Transl Med Date: 2015-11-05 Impact factor: 5.531
Authors: Anna M Tahvanainen; Antti J Tikkakoski; Jenni K Koskela; Klaus Nordhausen; Jani M Viitala; Miia H Leskinen; Mika A P Kähönen; Tiit Kööbi; Marko T Uitto; Jari Viik; Jukka T Mustonen; Ilkka H Pörsti Journal: BMC Cardiovasc Disord Date: 2016-05-23 Impact factor: 2.298
Authors: Alexander N Bennett; Daniel Mark Dyball; Christopher J Boos; Nicola T Fear; Susie Schofield; Anthony M J Bull; Paul Cullinan Journal: BMJ Open Date: 2020-10-30 Impact factor: 2.692
Authors: Rui Cao; Iman Azimi; Fatemeh Sarhaddi; Hannakaisa Niela-Vilen; Anna Axelin; Pasi Liljeberg; Amir M Rahmani Journal: J Med Internet Res Date: 2022-01-18 Impact factor: 5.428